RE:Interesting trading today so farFor those that watched the FDA advisory panel yesterday will know that the cardiovascular risks like high blood pressure and heart rate were a major concern by the panal and Pharmala's MDMA patented molecule addresses that concern. Their studies have shown significant reduction in that area. I would think Nick should actually have more leverage in obtaining a partnership with a large pharmaceutical company for clinical studies with their MDMA molecule then a company that doesn't have these MDMA patented derivatives.